Monitor for future equity issuances under the expanded plan, but no near-term trading catalyst. The filing is routine and does not change the company's financial outlook.
Price Chart
Executive Summary
Edwards Lifesciences reported the results of its 2026 Annual Meeting, where stockholders approved an amendment to the Long-Term Stock Incentive Compensation Program, increasing the share pool by 7 million shares to 341.5 million. All director nominees were elected, and other proposals including say-on-pay and auditor ratification passed. This is a routine administrative filing with no material financial impact.
Key Facts
- Stockholders approved Amended and Restated Long-Term Stock Incentive Compensation Program, increasing share pool by 7,000,000 shares to a total of 341,500,000 shares.
- All nine director nominees were elected with majority votes.
- Advisory vote on executive compensation passed with 424,961,639 for and 50,924,101 against.
- Ratification of PricewaterhouseCoopers as independent auditor approved with 446,283,142 for and 56,814,075 against.
- Vote on the compensation plan passed with 456,675,201 for and 19,210,539 against.
Financial Impact
No immediate financial impact; potential future dilution from increased share authorization is minimal relative to outstanding shares.
Risk Factors
- Potential dilution from future equity grants under the expanded share pool.
- No other material risks identified.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001099800-26-000028 |
| Document: 0001099800-26-000028-index-headers.html | 0001099800-26-000028 |
| Document: 0001099800-26-000028-index.html | 0001099800-26-000028 |
| Document: 0001099800-26-000028.txt | 0001099800-26-000028 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 31, 2026 4w ago | Insider Cluster | $90.74 $86.32 | ▼ −4.87% | ▼ −5.19% | $85.76 (−5.49%) |
Aug 28, 2026 5w ago | Insider Cluster | $90.21 $86.29 | ▼ −4.35% | ▼ −4.85% | $85.76 (−4.93%) |
Aug 26, 2026 5w ago | Insider Cluster | $89.95 $85.47 | ▼ −4.99% | ▼ −4.88% | $85.76 (−4.66%) |
Aug 10, 2026 7w ago | Court Ruling | $91.94 $86.72 | ▼ −5.67% | ▼ −4.76% | $85.76 (−6.72%) |
Jul 30, 2026 9w ago | Insider Cluster | $86.07 $90.21 | ▲ +4.81% | ▲ +1.82% | $85.76 (−0.36%) |
Jul 28, 2026 9w ago | Insider Cluster | $85.76 $90.78 | ▲ +5.85% | ▲ +0.83% | $85.76 (+0.00%) |
May 29, 2026 17w ago | Insider Cluster | $88.17 $91.18 | ▲ +3.42% | ▲ +5.73% | $85.76 (−2.73%) |
May 18, 2026 19w ago | Insider Cluster | $82.11 $88.58 | ▲ +7.88% | ▲ +5.62% | $85.76 (+4.45%) |
May 18, 2026 19w ago | Insider Cluster | $82.11 $88.58 | ▲ +7.88% | ▲ +5.62% | $85.76 (+4.45%) |
May 8, 2026 20w ago | 8-K | $77.08 $87.54 | ▲ +13.57% | ▲ +13.88% | $85.76 (+11.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access